Figure 1. Statistical Trends in Device Approvals and Supplement Use.
A, Original Class III device approval rates show no observable trend over the study period (January 1980-November 2016). B, Supplement use during the same period has statistically significantly increased, with a stronger observable trend over the past decade. PMA indicates premarket approval.